KGKader Gülmez

Kader Gülmez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kader Gülmez has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effect of ELF-EMF on cognitive functions, analgesia, and oxidative stress in rats with PTZ-induced epilepsy

    by Kader Gülmez, Ayşe Demirkazık, Ahmet Şevki Taşkıran

    This study aimed to examine the impacts of extremely low-frequency (ELF)-electromagnetic field (EMF) on cognitive functions and analgesia in terms of total oxidant status (TOS) and total antioxidant status (TAS) in the experimental pentylenetetrazole (PTZ)-induced epilepsy model. Twenty-four Wistar albino male rats were categorized into four groups: sham, EMF, PTZ, and EMF+PTZ. The rats were repeatedly exposed to alternating 50-Hz and 5-mT EMF for 165 min a day for 7 days. Epileptic seizures were induced with PTZ. The levels of oxidative stress markers were measured. Univariate multifactorial one-way analysis of variance and post hoc Tukey's test were used for pairwise comparisons between groups. A statistically significant difference was observed in the learning and short-term memory levels in the EMF + PTZ group compared with the PTZ group (p < 0.001). Analgesia latency statistically significantly increased in the ELF-EMF and ELF-EMF+PTZ groups compared with both the control and epilepsy groups (p < 0.001). A statistically significant increase in TOS was found in the prefrontal cortex in the PTZ group compared with the sham group (p < 0.001). Also, TOS statistically significantly increased in the hippocampus in both PTZ and ELF-EMF+ PTZ groups compared with the sham group (p < 0.001). ELF-EMF decreased the increased TOS in the hippocampus of rats in the PTZ group.


  • Protective Effect of Metformin Alone or in Combination with Valproic acid on Pentylenetetrazole-Induced Seizures in Mice

    by Erkan Gümüş, Mustafa Ergül, Kader Gülmez, Mustafa Ulu, Recep Akkaya, Ercan Özdemi̇r, Ahmet Şevki Taşkiran

    Objective: The aim of this study was to investigate the effects of metformin on pentylenetetrazole (PTZ)-induced seizures and the neuroprotective effect of metformin on neuronal damage after pentylenetetrazole administration. Material and Methods: Thirty-five (35) Male BALB-c Albino mice weighing 35-38 g were divided randomly into five groups: Control group (1), Saline+PTZ group (2), Valproic Acid (VPA, 200 mg/kg intraperitoneal-i.p.)+PTZ group (3), Metformin (200 mg/kg i.p.)+PTZ group (4), and VPA+Metformin+PTZ group (5). The PTZ (60 mg/kg, i.p.) was injected 30 min after drugs injection to induce seizures and seizure stages and behavioral scoring were evaluated. After completing procedure, brain tissues were removed and analyzed with biochemical and histopathological procedures. The hippocampal Cornu Ammonis (CA) 1, CA2, CA3 and DG (dentate gyrus) regions were histopathologically evaluated and oxidative stress markers (total antioxidant status (TAS), total oxidant status (TOS)) were measured. Results: Compare to Saline+PTZ group, metformin administration alone did not affect the onset time of the first myoclonic jerk (FMJ), but combination of VPA and metformin significantly increased FMJ onset time (p<0.05). Additionally, the treatment of metformin with or without VPA reduced the brain oxidative stress (p<0.05). Furthermore, histopathological assessment demonstrated that metformin administration and the combination of VPA and metformin decreased dark neuron formation in the hippocampal CA1, CA2, CA3, and DG areas (p<0.05). Conclusion: Metformin was found to be significantly effective in reducing epileptic seizures, brain oxidative stress, and preventing neural damage after PTZ-induced seizure